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Abstract
Background European nutritional guidelines recommend routine use of enteral feeding after pancreaticoduodenectomy (PD)
whereas American guidelines do not. Data on the efficacy and, especially, complications of the various feeding strategies
after PD are scarce.
Methods Retrospective monocenter cohort study in 144 consecutive patients who underwent PD during a period wherein the
routine post-PD feeding strategy changed twice. Patients not receiving nutritional support (n015) were excluded. Compli-
cations were graded according to the Clavien-Dindo classification and the International Study Group of Pancreatic Surgery
(ISGPS) definitions. Analysis was by intention-to-treat. Primary endpoint was the time to resumption of normal oral intake.
Results 129 patients undergoing PD (111 pylorus preserving) were included. 44 patients (34%) received enteral nutrition via
nasojejunal tube (NJT), 48 patients (37%) via jejunostomy tube (JT) and 37 patients (29%) received total parenteral nutrition
(TPN). Groups were comparable with respect to baseline characteristics, Clavien ≥II complications (P00.99), in-hospital stay
(P00.83) and mortality (P00.21). There were no differences in time to resumption of normal oral intake (primary endpoint;
NJT/JT/TPN: median 13, 16 and 14 days, P00.15) and incidence of delayed gastric emptying (P00.30). Duration of enteral
nutrition was shorter in the NJT- compared to the JT- group (median 8 vs. 12 days, P00.02). Tube related complications
occurred mainly in the NJT-group (34% dislodgement). In the JT-group, relaparotomy was performed in three patients (6%)
because of JT-leakage or strangulation leading to death in one patient (2%). Wound infections were most common in the TPN
group (NJT/JT/TPN: 16%, 6% and 30%, P00.02).
Conclusion None of the analysed feeding strategies was found superior with respect to time to resumption of normal oral
intake, morbidity and mortality. Each strategy was associated with specific complications. Nasojejunal tubes dislodged in a
third of patients, jejunostomy tubes caused few but potentially life-threatening bowel strangulation and TPN doubled the risk
of infections.
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Introduction
Pylorus-preserving pancreaticoduodenectomy (PD) is the
treatment of choice for (pre-)malignant neoplasms of the
pancreatic head, ampulla, distal bile duct and duodenum.
1
PD is associated with a relatively high morbidity rate, in-
cluding a high incidence of delayed gastric emptying.
2–4 The
current guidelines of the European Society for Parenteral
and Enteral Nutrition (ESPEN) recommend routine use of
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gastrointestinal surgery for cancer, including PD.
5 In contrast,
the current American Society of Parenteral and Enteral
Nutrition (ASPEN) guidelines recommend postoperative
nutritional support only in patients whom it is anticipated
will be unable to meet their nutrient needs orally for a period
of 7 to 10 days, which is not necessarily the case after PD.
6
Specific evidence concerning the optimal feeding strate-
gy after PD is scarce and hence the choice of feeding
strategy depends mainly on individual preference. Although
enteral and parenteral feeding after PD may be associated
with complications, there are surprisingly little data avail-
able on this subject.
In our department, the preferred routine post-PD feeding
strategy changed twice in the past 10 years; from jejunos-
tomy tube feeding (JT) to total parenteral nutrition (TPN) to
nasojejunal tube feeding (NJT). These changes were initiat-
ed by a perceived high rate of feeding-related complications
associated with the JTand TPN feeding strategies as well as
a lack of clear evidence in favour of any feeding technique.
The aim of this study was to assess the efficacy and feeding-
related complications of the various feeding strategies after
PD in a single tertiary referral center.
Methods
Patients
A retrospective monocenter cohort study was performed in
all 144 consecutive patients who underwent (pylorus pre-
serving) PD at the University Medical Center Utrecht, be-
tween January 1st 2001 and December 30th 2010. Patients
were categorised according to the feeding strategy decided
upon prior to or during surgery: enteral feeding via NJT or
JT, or TPN. Patients who could not be classified in these
three groups or had no follow-up were excluded (n015).
See the ‘Results’ section for details.
Surgical Approach
PD was performed by a team specialised in hepatobiliary
and pancreatic surgery. Reconstruction was typically per-
formed with end-to-side duct-to-mucosa pancreatojejunos-
tomy (ISGPS type IAS0),
7 end-to-side hepaticojejunostomy
and (antecolic) duodeno(gastro)jejunostomy.
Routes of Nutrition
Enteral nutrition was delivered via either nasojejunal tube or
jejunostomy tube. In the period January 2001–May 2010,
Nutrison Standard was used and since May 2010 Nutrison
Protein Plus (both from Nutricia, The Netherlands). In the
NJT group, a nasojejunal tube (Freka Trelumina Tube, Fre-
senius Kabi Ltd, UK) was advanced for at least 30 cm
through the duodenojejunostomy after the creation of the
dorsal part of this anastomosis. In the JT group, a jejunos-
tomy tube (Freka FCJ Set FR 9, Fresenius Kabi Ltd, UK)
was advanced through the abdominal wall and into the
bowel after the reconstruction phase of the pancreaticoduo-
denectomy. The tube was advanced for at least 30 cm and
fixated to the bowel and the abdominal wall. In both the NJT
and JT groups, enteral nutrition was started the first morning
postoperatively at a rate of 25 ml/h and increased with 25 ml
per day (2001–2009) or per 6 h (since May 2010) to the
required amount as advised by the consulting dietitian.
TPN (NuTRIflex Lipid Special, B. Braun, Germany) was
delivered via a central venous line. TPN was started the morn-
i n ga f t e rs u r g e r ya tar a t eo f4 2m l / ha n di n c r e a s e dw i t h5 0 0m l
per day to the required amount, according to dietitians’ advice.
In the NJT and JT groups, TPN was only given when
enteral feeding was unsuccessful, but according to the
intention-to-treat principle these patients remained in their
assigned groups.
Oral intake was started on patient’s request and modulated
depending on digestive symptoms. When oral intake
exceeded 50 % of the daily required caloric intake, enteral or
parenteral nutritional support was ceased. In the NJT group,
the feeding tube was removed at this stage. In the JT group,
the tube was only removed in the outpatient department
6 weeks postoperatively. Patients in the JT and TPN group
received a nasogastric tube for gastric decompression only if
necessary.
Definitions
Postoperative pancreatic fistula, delayed gastric emptying and
post-pancreatectomy haemorrhage were defined according to
the International Study Group of Pancreatic Surgery (ISGPS)
definitions.
8–10 All complications were graded according to
the Clavien–Dindo classification.
11 The postoperative course
was defined to be complicated if a complication occurred that
required medical therapy or any form of intervention
(Clavien–Dindo grade II or higher). Chyle leakage requiring
very low fat elemental enteral nutrition was graded as
Clavien–Dindo grade II, if there was no other indication for
enteral nutrition (anymore). Infectious complications had to
be confirmed by a positive culture result. Severe preoperative
weightlosswas defined asweightlossof10% ormorewithin
6 months or 5 % or more within 1 month prior to surgery.
Data Collection
Data were retrospectively collected from computerised clin-
ical records. Baseline characteristics collected were patient
demographics, body mass index (BMI), severe preoperative
J Gastrointest Surg (2012) 16:1144–1151 1145weight loss, indication for surgery, diagnosis, surgeon, type
of surgery, operative time and blood loss.
Primary outcome was the time to resumption of normal oral
intake, defined as the postoperative day on which intake was
reported to be adequate by the treating physician or dietitian.
Secondary outcomes were time to start of oral and solid
food intake, duration of (par)enteral nutrition, use of proki-
netic agents, postoperative surgical, general and tube-related
complications (in-hospital and during readmission), inci-
dence of postoperative pancreatic fistula, delayed gastric
emptying, post-pancreatectomy haemorrhage and chyle
leakage, length of hospital stay, readmission within 30 days
after discharge, relaparotomy and in-hospital mortality.
Statistical Analysis
Analysis was by intention-to-treat. Values are expressed as
median and interquartile range, unless specified otherwise.
Data were analysed using SPSS for Windows version 15.0
(SPSS Inc., Chicago, IL, USA). Continuous non-normally
distributed variables were compared using the Kruskal–
Wallis or Mann–Whitney U test, and categorical variables
were compared by chi-square or Fisher’s exact test as ap-
propriate. For multivariable analysis, the binary logistic
regression model was used. Statistical dependence between
two non-parametric variables was assessed by Spearman
correlation. A P value <0.05 was considered significant.
Results
Patients
Of the 144 patients who had undergone a (pylorus preserv-
ing) PD in the study period, 15 patients were excluded
because they had no nutritional support (n09), received
enteral nutrition via nasogastric tube (n04), underwent a
modified surgical intervention (status after previous total
gastrectomy, n01) or were transferred to another hospital
(n01) leaving 129 patients eligible for further analysis.
Of these 129 patients, 44 (34 %) received enteral nutri-
tion via NJT, 48 patients (37 %) via JT and 37 patients
(29 %) received TPN. Baseline characteristics, including
age, gender, BMI, severe preoperative weight loss, indica-
tion for surgery, diagnosis, procedure and blood loss did not
differ between the groups (see Table 1). The three groups
only differed in terms of the surgeon performing the proce-
dure and the operative time.
Table 1 Baseline characteristics
BMI body mass index, PD pan-
creaticoduodenectomy, RBC red
blood cells, FFP fresh frozen
plasma
a17% missing data
bWhipple's PD (n 0 5),
PD + hemicolectomy (n 0 3), PD
+ hemicolectomy + nefrectomy
(n 0 3), PD + hemicolectomy +
portal vein (n 0 2), PD +
portal vein (n 0 5), PD + partial
corpus/cauda resection (n 0 2),
total pancreatectomy (n 0 1),
total pancreatectomy +
portal vein (n 0 1)
cKruskal–Wallis test
dChi-square test
eFisher's exact test
Nasojejunal tube Jejunostomy tube Total parenteral
nutrition
P value
(n 0 44) (n 0 48) (n 0 37)
Male 59% 69% 57% 0.47
d
Age 63 (61–67) 65 (57–72) 66 (60–72) 0.34
c
BMI 24.2 (22.0–26.7) 24.3 (22.8–25.9) 23.8 (22.0–26.9) 0.96
c
Severe preoperative weight loss
a 15 (34%) 14 (41%) 10 (34%) 0.79
d
Indication 0.62
d
Suspected malignancy 21 (48%) 33 (69%) 23 (62%)
Proven malignancy 14 (32%) 11 (23%) 10 (27%) 0.29
e
Other 9 (20%) 4 (8%) 4 (11%)
Diagnosis 0.28
e
Pancreatic adenocarcinoma 19 (43%) 23 (48%) 11 (30%)
Ampullary adenocarcinoma 4 (9%) 11 (23%) 8 (22%)
Cholangiocarcinoma 6 (14%) 3 (6%) 7 (19%)
Benign 7 (16%) 3 (6%) 4 (11%)
Other 8 (18%) 8 (17%) 7 (19%)
Procedure 0.13
d
Pylorus-preserving PD 34 (77%) 44 (92%) 29 (78%)
Extended PD
b 10 (23%) 4 (8%) 8 (22%)
Intraoperative parameters
Operative time (min) 370 (318–438) 291 (265–361) 367 (312–412) 0.001
c
Blood loss (cc) 800 (500–1,350) 1,000 (550–1,500) 800 (575–1,500) 0.43
c
RBC transfusion (U) 0 (0–0) 0 (0–2) 0 (0–1) 0.20
c
FFP transfusion (U) 0 (0–0) 0 (0–0) 0 (0–0) 0.72
c
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Time to resumption of normal oral intake (primary endpoint)
did not differ between the three groups, with a median dura-
tion of 13 (10–19), 16 (13–24) and 14 (10–22) days in the
NJT, JT and TPN group, respectively (P00.15). Duration of
enteral nutrition was significantly shorter in the NJT group
compared to the JT group [median 8 (6–12) vs. 12 (8–18)
days, P00.02]. Time to start of oral intake was significantly
shorterintheTPN-group,withamediandurationof5(3–7),5
(4–11) and 4 (2–5) days in the NJT, JT and TPN group,
respectively (P00.02). All outcomes of nutritional and hospi-
talisation parameters are shown in Table 2.
General Complications
Morbidity and mortality rates are shown in Table 3.O v e r a l l
morbidityrequiringtherapyorintervention(Clavien–Dindograde
II or higher) and mortality did not differ between the groups.
Surgical and general complication rates are listed in
Table 4. The rates of clinically relevant postoperative pan-
creatic fistula (grade B/C, ISGPF), delayed gastric emptying
(grade B/C, ISPGS) and postoperative haemorrhage (grade
B/C, ISGPS) did not differ between the groups (overall rates
12 %, 42 % and 10 %, respectively).
Feeding-Related Complications
Tube-related complications were more common in the NJT
group as compared to the JT group (41 % vs. 23 %, P0
0.06). This difference was mainly caused by a 34 % (n015)
dislodgement rate of the intraoperatively placed nasojejunal
tubes (Table 5). These dislodgements occurred after a me-
dian of 7 (5–12) days. Tubes were replaced in eight of the 15
patients. The complications in the JT group tended to be
more severe, including leakage and torsion of the small
bowel around the tube, requiring four relaparotomies in
three patients (6 %) and eventually leading to death in one
patient (2 %), due to multi-organ failure caused by small
bowel ischaemia. The rate of wound infections was signif-
icantly higher in the TPN group (NJT/JT/TPN016 %, 6 %
and 30 %, P00.02).
Multivariable Analysis
The patient volume increased during the 10-year study
period. Average annual volume in the first 3 years was 5
versus 25 in the last 3 years (P00.001). Therefore, year of
procedure was entered as a variable in a multivariable lo-
gistic regression analysis that also adjusted for differences in
age, gender, BMI and surgeon. After adjustment, there still
was no difference between the three feeding strategies in the
rate of morbidity or mortality.
Age and gender were found to be an independent factor
influencing morbidity (Clavien–Dindo grade II or higher). A
1-year increase in age had an OR of 1.05 in developing a
complication (P00.02). The male gender had an OR of 2.48
in developing a complication compared to the female gender
(P00.02). No independent factors for mortality were found.
Table 2 Nutritional and hospitalisation parameters
Nasojejunal tube Jejunostomy tube Total parenteral nutrition P value P value
(n 0 44) (n 0 48) (n 0 37) Enteral only
a
Primary endpoint
Time to resumption of normal oral intake (days) 13 (10–19) 16 (13–24) 14 (10–22) 0.15
c 0.09
b
Secondary endpoints
Duration of enteral nutrition (days) 8 (6–12) 12 (8–18) 0 (0–0) 0.02
b
Duration of parenteral nutrition (days) 0 (0–6) 0 (0–0) 9 (7–14) 0.06
b
Time to start oral intake (days) 5 (3–7) 5 (4–11) 4 (2–5) 0.02
c 0.11
b
Time to start solid food intake (days) 9 (6–12) 12 (9–17) 9 (7–13) 0.10
c 0.06
b
Use of prokinetics (n) 12 (27%) 23 (48%) 14 (38%) 0.15
d 0.05
d
Length of hospital stay (days) 17 (12–23) 19 (14–24) 16 (13–27) 0.83
c 0. 58
d
Readmission within 30 days (n) 2 (4.5%) 3 (6.3%) 6 (16.2%) 0.19
e 1.00
e
aNasojejunal vs jejunostomy tube
bMann–Whitney U test
cKruskal–Wallis test
dChi-square test
eFisher's exact test
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Nasojejunal tube Jejunostomy tube Total parenteral nutrition P value P value
(n 0 44) (n 0 48) (n 0 37) Enteral only
a
Overall morbidity
Clavien–Dindo grade I–V 37 (84%) 44 (92%) 34 (92%) 0.49
e 0.26
d
Clavien–Dindo grade ≥II 27 (61%) 30 (63%) 23 (62%) 0.99
d 0.91
d
Surgical morbidity
b 36 (82%) 43 (90%) 33 (89%) 0.52
e 0.29
d
General morbidity
c 20 (45%) 26 (54%) 17 (39%) 0.55
d 0.40
d
Tube-related morbidity 18 (41%) 11 (23%) 6 (16%) 0.03
d 0.06
d
Relaparotomy 7 (16%) 8 (17%) 7 (19%) 0.93
d 0.92
d
Number of procedures 19 15 13
of which tube related 0 4 0
Mortality 2 (4.5%) 6 (12.5%) 1 (2.7%) 0.21
e 0.27
e
of which tube related 0 1 0
aNasojejunal vs jejunostomy tube
bIncluding pancreatic fistula, delayed gastric emptying, postoperative haemorrhage, ileus, anastomotic bowel leak, chyle leak, biliary leak, fascial
dehiscence, bowel ischaemia, enterocutaneous fistula, cholangitis, wound infection and intra-abdominal abscess
cIncluding line infection, urinary tract infection, pneumonia, deep venous thrombosis and pulmonary embolism
dChi-square test
eFisher's exact test
Table 4 General and surgical morbidity
Nasojejunal tube Jejunostomy tube Total parenteral nutrition P value P value
(n 0 44) (n 0 48) (n 0 37) Enteral only
a
Pancreatic fistula (grade B/C) 5 (11%) 6 (13%) 4 (11%) 1.00
c
Delayed gastric emptying (grade B/C) 15 (34%) 24 (50%) 15 (40%) 0.30
b
Postoperative haemorrhage (grade B/C) 6 (14%) 4 (8%) 3 (8%) 0.67
c
Ileus 2 (5%) 5 (10%) 0 (0%) 0.13
c
Anastomic bowel leak 1 (2%) 0 (0%) 0 (0%) 0.63
c
Chyle leak 9 (20%) 11 (23%) 2 (5%) 0.08
b
Biliary leak 5 (11%) 4 (8%) 3 (8%) 0.86
c
Fascial dehiscence 2 (5%) 0 (0%) 3 (8%) 0.13
c
Bowel ischaemia 1 (2%) 1 (2%) 0 (0%) 1.00
c
Enterocutaneous fistula 1 (2%) 0 (0%) 1 (3%) 0.53
c
Other surgical complications 3 (7%) 2 (4%) 2 (5%) 0.89
c
Infections
Cholangitis 3 (7%) 0 (0%) 2 (5%) 0.22
c
Wound infection 7 (16%) 3 (6%) 11 (30%) 0.02
b 0.19
c
Intra-abdominal abscess 3 (7%) 1 (2%) 2 (5%) 0.58
c
Line infection 8 (18%) 7 (15%) 3 (8%) 0.42
b
Urinary tract infection 6 (14%) 6 (13%) 3 (8%) 0.79
c
Pneumonia 9 (20%) 8 (17%) 4 (11%) 0.50
b
Deep venous thrombosis 1 (2%) 1 (2%) 0 (0%) 1.00
c
Pulmonary embolism 3 (7%) 1 (2%) 2 (5%) 0.58
c
Other general complications 10 (23%) 12 (25%) 14 (32%) 0.27
b
aNasojejunal vs jejunostomy tube, only reported when overall P value <0.05
bChi-square test
cFisher's exact test
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This is the largest comparative study to date on efficacy and
complications of jejunostomy, nasojejunal and total paren-
teral feeding after PD. None of the feeding strategies was
found superior with respect to time to resumption of normal
oral intake, morbidity and mortality. Each strategy was
associated with specific complications. Nasojejunal tubes
dislodged in a third of patients, jejunostomy tubes caused
few but potentially life-threatening bowel strangulation and
TPN doubled the risk of wound infections. Although these
complications varied widely in both incidence and severity,
it seems that if feeding is desired a nasojejunal tube is the
feeding strategy of choice, as replacement of a nasojejunal
tube (although frequently required) is to be preferred over
infections and bowel strangulation.
Only one study previously compared the efficacy and
safety of different routes of enteral nutritional support after
PD.
12 This monocenter cohort study analysed 100 patients
receiving enteral nutrition via either percutaneous transper-
itoneal jejunostomy, gastrojejunostomy or nasojejunal tube.
This study did not use ISGPS definitions or multivariable
analysis to account for confounders such as surgeon’s pref-
erence. As in our study, no significant differences were
observed between the groups in time to resumption of
normal oral intake, as well as in hospital stay, while duration
of feeding was significantly shorter in NJT patients. Tube
related complications, however, were observed less fre-
quently than in our study. Dislodgement of the NJT was
seen in only 5 % of patients, as compared to 34 % in our
study. The authors stated this relatively low dislodgement
rate to be caused by the use of a tube with a wider diameter
(10/8 French), enabling more secure fixation at the nostrils.
The tubes used in our study, however, have an even larger
diameter (16/9 French) due to the three lumina. In the
general feeding literature, a dislodgement rate of NJTs of
16–36 % has been reported.
13–17 Several techniques have
been described to prevent inadvertent NJT dislodgement.
One of the most successful ones is nasal bridling.
18 In a
randomised controlled trial (n080), comparing the nasal
bridle technique with an adhesive tape device, dislodgement
rate was reduced from 63 % in the unbridled to 18 % in the
bridled group, with only few and minor adverse events.
19
Another technique is the clipping of the tip of the nasojejunal
tube to the bowel mucosa,
20 but this is impractical during
laparotomy.
Although rare, bowel strangulation and leakage are well-
known, potentially lethal complications of percutaneous
jejunostomy tubes. In a series of 2,022 patients undergoing
laparotomy for mostly complex upper-abdominal opera-
tions, jejunostomy resulted in 34 tube-related complications
in 29 patients (1.5 %).
21 The most common complication
was occlusion or dislodgement in 15 patients (0.7 %), and
the most serious complication was bowel necrosis in three
patients (0.2 %), leading to death in two patients. Intestinal
occlusion and volvulus was described in three patients
(0.2 %), leading to death in one and intra-abdominal infec-
tions in three other (0.2 %). A literature review in 1,788
patients with jejunostomy tubes found a strangulation rate of
0.3 % and an intra-abdominal infection rate of 0.8 %.
21
Increased risk of infections with the use of parenteral
nutrition is also well known. A meta-analysis by
Braunschweig et al., combining 27 randomised controlled
trials (n01,827), found a significantly increased risk of infec-
tions with parenteral compared to enteral nutrition (RR
0.64),
22 corresponding with the results of a previous study in
patients after PD.
23
Duration of enteral nutrition was found to be significantly
shorter in the NJT group compared to the JT group (median
8 vs. 12 days). This can be explained by the fact that enteral
Table 5 Tube-related morbidity
Nasojejunal tube Jejunostomy tube Total parenteral nutrition P value P value
(n 0 44) (n 0 48) (n 0 37) Enteral only
a
Dislodgement of primary placed tube 15 (34%) 4 (8%) 3 (8%) 0.001
d 0.002
d
Disabling blockage 4 (9%) 5 (10%) 0 (0%) 0.11
e 1.00
e
Infection of feeding tube/central venous line
b 0 (0%) 1 (2%) 3 (8%) 0.10
e 1.00
e
Haemorrhage (not requiring transfusion) 0 (0%) 2 (4%) 0 (0%) 0.33
e 0.50
e
Other
c 0 (0%) 5 (10%) 0 (0%) 0.01
e 0.06
e
Tube-related relaparotomy 0 (0%) 3 (6%) 0 (0%) 0.11
e 0.24
e
Tube-related mortality 0 (0%) 1 (2%) 0 (0%) 1.00
e 1.00
e
aNasojejunal vs jejunostomy tube
bSee Table 4 for all infectious complications
cSmall bowel leakage (n=2), bowel torsion (n=2), subcutaneous emphysema and fluid collection around insertion site (n=1)
dChi-square test
eFisher's exact test
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dislodgement, and attempts to stop enteral nutrition were
undertaken earlier to stimulate oral intake and relief patients
of their tube before discharge.
The strength of the current study lies in the use of the
generally accepted ISGPS definitions and the Clavien–
Dindo classification for postoperative complications, mak-
ing comparison of data more reliable. It is known that the
use of the ISGPS definitions results in a relatively high
incidence of complications.
3 The main limitation of this
study is its retrospective design and therefore nonrandom
(but rather chronological) allocation of patients into the
different feeding strategies. Furthermore, during the study
period the annual volume of PD increased. However, as
there was no relation between the studies primary endpoint
(time to resumption of normal oral intake) and surgeon (P0
0.50) or year of surgery (P00.21), we feel the impact of
these confounders is small. The group of patients with an
oral diet after PD was too small and heterogeneous for
reliable conclusions and hence not included in the analysis.
Interestingly, several large studies found good results
with a normal oral diet (without routine nutritional support)
after PD. Yermilov et al. reviewed the California Cancer
Registry (1994–2003) for outcomes of 1,873 patients who
underwent PD for adenocarcinoma receiving either paren-
teral feeding (14 %), jejunostomy tube feeding (23 %) or an
oral diet without supplemental nutritional support (63 %).
This study did not include data on nasojejunal feeding. They
showed a significantly shorter length of hospital stay in the
normal diet cohort.
24 Martignoni et al. prospectively studied
a cohort of 64 patients and reported, besides an increase in
length of stay, a significantly higher prevalence of delayed
gastric emptying in patients with enteral nutrition, compared
to patients with an oral diet.
25 In contrast to these studies,
two other studies suggest that routine enteral nutrition is
better than ‘standard care’. In a randomised controlled trial
(n036) by Mack et al., length of hospital stay was reduced
by routine gastrojejunostomy tube feeding as compared to
‘standard care‘ after PD.
26 This study did not define ‘stan-
dard care’. Baradi et al. retrospectively studied patients with
postoperative nasojejunal or gastrojejunal tube feeding or an
oral diet after PD (n0180). Enteral feeding was associated
with significantly less use of TPN and lower rates of read-
mission and complications. Length of stay did not differ
between the two groups.
27
If an oral postoperative diet is used, what strategy should
be followed? A recent review suggested that implementation
of a fast-track perioperative pathway [or enhanced recovery
after surgery (ERAS) program] in pancreatic surgery could
lead to reduced hospital stay and reduced costs without an
increase in morbidity, mortality or re-admission rates.
28
The discrepancy between current European ‘routine’ and
American ‘on demand’ guidelines and the feeding related
complications described in this study support use of the
American ‘on demand’ nutrition guidelines. One could ar-
gue that patients should be started on a regular oral diet as
soon as possible after PD as is current practice after most
other major surgeries. Only in case of severe preoperative
weight loss or a complicated postoperative course (such as
pancreatic fistula),
29 enteral nutrition should be started. This
‘on demand’ strategy would prevent many patients from the
discomfort of a feeding tube/line and would save the addi-
tional costs of enteral feeding. Future randomised studies
should test this hypothesis by comparing outcomes of a
routine oral diet (with on demand nasojejunal feeding) with
routine nasojejunal feeding after PD.
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